Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Neurobiology of Disease|October 26, 2005
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosisAna Cabranes, Katerina Venderova, Eva de Lago, et al.Bioorganic & Medicinal Chemistry Letters|December 15, 2012
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition propertiesStefania Butini, Sandra Gemma, Margherita Brindisi, et al.Bioorganic & Medicinal Chemistry Letters|July 2, 2010
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolaseSonia Gattinoni, Chiara De Simone, Sabrina Dallavalle, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 19, 2007
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatumDiego Centonze, Silvia Rossi, Ilaria Napoli, et al.ACS Chemical Biology|April 28, 2022
Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437Berend Gagestein, Anna F Stevens, Domenico Fazio, et al.British Journal of Pharmacology|September 8, 2011
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signallingSergio Oddi, Enrico Dainese, Simone Sandiford, et al.Journal of Medicinal Chemistry|July 12, 2012
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolasesStefania Butini, Margherita Brindisi, Sandra Gemma, et al.British Journal of Pharmacology|September 24, 2015
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicityPartha Mukhopadhyay, Marc Baggelaar, Katalin Erdelyi, et al.Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptorsSusan M Huang, Tiziana Bisogno, Marcello Trevisani, et al.European Journal of Medicinal Chemistry|September 14, 2019
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systemsAlessandro Grillo, Giulia Chemi, Simone Brogi, et al.Pageof 7